Сједињене Америчке Државе - Енглески - NLM (National Library of Medicine)

genzyme corporation - sevelamer hydrochloride (unii: gls2pgi8qg) (sevelamer - unii:941n5duu5c) - sevelamer hydrochloride 400 mg - renagel ® is indicated for the control of serum phosphorus in patients with chronic kidney disease (ckd) on dialysis. the safety and efficacy of renagel in ckd patients who are not on dialysis have not been studied. renagel is contraindicated in patients with bowel obstruction. renagel is contraindicated in patients with known hypersensitivity to sevelamer hydrochloride or to any of the excipients. risk summary sevelamer hydrochloride is not absorbed systemically following oral administration and maternal use is not expected to result in fetal exposure to the drug. clinical considerations sevelamer hydrochloride may decrease serum levels of fat-soluble vitamins and folic acid in pregnant women [see clinical pharmacology (12.2)] . consider supplementing with these vitamins. data animal data in pregnant rats given dietary doses of 0.5, 1.5, or 4.5 g/kg/day of renagel during organogenesis, reduced or irregular ossification of fetal bones, probably due to a reduced absorption of fat-soluble vit

Панама - Енглески - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

sandoz gmbh - sevelamero carbonato anhidro - sevelamero carbonato anhidro....800.00 mg

Панама - Енглески - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

genthon b.v. - sevelamero carbonato anhidro - sevelamero carbonato anhidro....800.00 mg

Панама - Енглески - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

genthon b.v. - sevelamero carbonato anhidro - sevelamero carbonato anhidro....800.00 mg.

Израел - Енглески - Ministry of Health

sanofi israel ltd - sevelamer carbonate anhydrous - film coated tablets - sevelamer carbonate anhydrous 800 mg - sevelamer - sevelamer - for the control of hyperphosphataemia in adult patients receiving haemodialysis or peritoneal dialysis.also indicated for the control of hyperphosphataemia in adult patients with chronic kidney disease not on dialysis with serum phosphorus ≥ 1.78 mmol/l.should be used within the context of a multiple therapeutic approach, which could include calcium supplement, 1,25-dihydroxy vitamin d3 or one of its analogues to control the development of renal bone disease.

Израел - Енглески - Ministry of Health

sanofi israel ltd - sevelamer carbonate anhydrous - powder for suspension - sevelamer carbonate anhydrous 2.4 g/sachet - sevelamer - sevelamer - for the control of hyperphosphataemia in adult patients receiving haemodialysis or peritoneal dialysis.also indicated for the control of hyperphosphataemia in adult patients with chronic kidney diseasenot on dialysis with serum phosphorus ≥ 1.78 mmol/l.should be used within the context of a multiple therapeutic approach, which could include calcium supplement, 1,25-dihydroxy vitamin d3 or one of its analogues to control the development of renal bone disease.

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - sevelamer carbonate -

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - sevelamer carbonate -

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - sevelamer carbonate -

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - sevelamer hydrochloride, quantity: 800 mg - tablet, film coated - excipient ingredients: colloidal anhydrous silica; stearic acid; hypromellose; acetylated monoglycerides; propylene glycol; isopropyl alcohol; purified water; iron oxide black - renagel is indicated for the management of hyperphosphataemia in adult patients with stage 4 and 5 chronic kidney disease.